Clinical trials update: highlights of the scientific sessions of the American Heart Association year 2000: Val HeFT, COPERNICUS, MERIT, CIBIS-II, BEST, AMIOVIRT, V-MAC, BREATHE, HEAT, MIRACL, FLORIDA, VIVA and the first human cardiac skeletal muscle myoblast transfer for heart failure

Eur J Heart Fail. 2001 Jan;3(1):117-24. doi: 10.1016/s1388-9842(00)00145-8.

Abstract

This article continues a series of reports summarising recent research developments pertinent to the topic of heart failure. This is a summary of presentations made at scientific sessions of the American Heart Association in November 2000. Clinical studies of particular interest to people caring for patients with heart failure include Val-HeFT, AMIOVIRT and V-MAC. New data from beta-blockers trials are reviewed, highlights from some important developments in post-infarction care, including MIRACL and FLORIDA, discussed and results of some early studies of gene therapy reported.

Publication types

  • Clinical Trial
  • Congress
  • Randomized Controlled Trial

MeSH terms

  • Animals
  • Clinical Trials as Topic*
  • Defibrillators, Implantable
  • Genetic Therapy
  • Heart Failure / drug therapy*
  • Heart Failure / therapy
  • Humans
  • Muscle, Skeletal / cytology